Fuji Pharma Co Ltd
TSE:4554
Intrinsic Value
Fuji Pharma Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products. [ Read More ]
The intrinsic value of one Fuji Pharma Co Ltd stock under the Base Case scenario is 2 449.16 JPY. Compared to the current market price of 1 626 JPY, Fuji Pharma Co Ltd is Undervalued by 34%.
Valuation Backtest
Fuji Pharma Co Ltd
Run backtest to discover the historical profit from buying and selling Fuji Pharma Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Our AI Assistant is coming soon! Stay tuned and thank you for your interest!
Provide an overview
of Fuji Pharma Co Ltd's business.
What risks and challenges
does Fuji Pharma Co Ltd face in the near future?
Summarize the latest earnings report
of Fuji Pharma Co Ltd.
Provide P/E
for Fuji Pharma Co Ltd and its competitors.
Balance Sheet Decomposition
Fuji Pharma Co Ltd
Current Assets | 40.4B |
Cash & Short-Term Investments | 2.2B |
Receivables | 16.7B |
Other Current Assets | 21.5B |
Non-Current Assets | 44.2B |
Long-Term Investments | 6.1B |
PP&E | 21.2B |
Intangibles | 10.3B |
Other Non-Current Assets | 6.5B |
Current Liabilities | 27.7B |
Accounts Payable | 6.8B |
Accrued Liabilities | 264m |
Short-Term Debt | 11.3B |
Other Current Liabilities | 9.4B |
Non-Current Liabilities | 14.9B |
Long-Term Debt | 12.4B |
Other Non-Current Liabilities | 2.5B |
Earnings Waterfall
Fuji Pharma Co Ltd
Revenue
|
41.6B
JPY
|
Cost of Revenue
|
-25.6B
JPY
|
Gross Profit
|
16B
JPY
|
Operating Expenses
|
-13.5B
JPY
|
Operating Income
|
2.5B
JPY
|
Other Expenses
|
2.5B
JPY
|
Net Income
|
5.1B
JPY
|
Free Cash Flow Analysis
Fuji Pharma Co Ltd
What is Free Cash Flow?
Profitability Score
Profitability Due Diligence
Fuji Pharma Co Ltd's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
Score
Fuji Pharma Co Ltd's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Fuji Pharma Co Ltd's solvency score is 60/100. The higher the solvency score, the more solvent the company is.
Score
Fuji Pharma Co Ltd's solvency score is 60/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Fuji Pharma Co Ltd
According to Wall Street analysts, the average 1-year price target for Fuji Pharma Co Ltd is 2 132.31 JPY with a low forecast of 2 000.81 JPY and a high forecast of 2 310 JPY.
Shareholder Return
Price
Fuji Pharma Co Ltd
Average Annual Return | -10.66% |
Standard Deviation of Annual Returns | 10.56% |
Max Drawdown | -49% |
Market Capitalization | 39.5B JPY |
Shares Outstanding | 24 305 000 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Fuji Pharma Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 1,532 full-time employees. The firm is engaged in the manufacture and sale of hormone medicines for obstetrics and gynecology department, as well as injectable drugs for radiological department such as radiopaque dye for urinary tracts and blood vessels through its branches. In addition, the Company purchases its main pharmaceutical ingredients from its main parent company.
Contact
IPO
Employees
Officers
The intrinsic value of one Fuji Pharma Co Ltd stock under the Base Case scenario is 2 449.16 JPY.
Compared to the current market price of 1 626 JPY, Fuji Pharma Co Ltd is Undervalued by 34%.